Alliancebernstein L.P. Aurinia Pharmaceuticals Inc. Transaction History
Alliancebernstein L.P.
- $287 Billion
- Q3 2024
A detailed history of Alliancebernstein L.P. transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 135,500 shares of AUPH stock, worth $1.09 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
135,500
Previous 135,500
-0.0%
Holding current value
$1.09 Million
Previous $773,000
28.46%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding AUPH
# of Institutions
214Shares Held
58.3MCall Options Held
1.14MPut Options Held
1.51M-
Black Rock Inc. New York, NY9.27MShares$74.3 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY8.2MShares$65.7 Million1.0% of portfolio
-
Tang Capital Management LLC San Diego, CA7.23MShares$57.9 Million4.52% of portfolio
-
Nea Management Company, LLC Timonium, MD3.97MShares$31.8 Million2.22% of portfolio
-
State Street Corp Boston, MA2.95MShares$23.6 Million0.0% of portfolio
About Aurinia Pharmaceuticals Inc.
- Ticker AUPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,892,000
- Market Cap $1.14B
- Description
- Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...